SCHEMBL9115028

SCHEMBL9115028

O=P(O)(Nc1ccccc1)Oc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.66
SRC P12931 1/20 0.57
LMNA P02545 5/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
HTT P42858 2/20 0.54
PKM P14618 1/20 0.54
HPGD P15428 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HCRTR1 O43613 1/20 0.47
CA9 Q16790 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22323438 0.81 SRC (0.64) KDM4ESRCLMNAMEN1KMT2A
SCHEMBL25348379 0.79 SRC (0.61) KDM4ESRCLMNAMEN1KMT2A
SCHEMBL7740418 0.79 MEN1 (0.76) KDM4ESRCLMNAMEN1KMT2A
SCHEMBL132235 0.79 KDM4E (0.92) KDM4ESRCLMNAMEN1KMT2A
SCHEMBL7734146 0.79 KDM4E (1.00) KDM4ELMNAMEN1KMT2AHTT
SCHEMBL17319264 0.78 HPGD (0.53) KDM4ELMNAMEN1KMT2AHTT
SCHEMBL5594628 0.78 SRC (0.59) KDM4ESRCLMNAMEN1KMT2A
SCHEMBL4338564 0.78 SRC (0.59) KDM4ESRCLMNAMEN1KMT2A
SCHEMBL10886221 0.77 KDM4E (0.85) KDM4ELMNAMEN1KMT2AHTT
Phenyl Dihydrogen Phosphate SCHEMBL8374921 0.76 SRC (0.95) KDM4ESRCLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871693-B2 Volatile-phosphorus free gelling agents GASFRAC ENERGY SERVICES INC. (CA) 2014-10-28 US disclosed
US-8871693-B2 Volatile-phosphorus free gelling agents GASFRAC ENERGY SERVICES INC. (CA) 2014-10-28 US disclosed
US-20110143971-A1 VOLATILE-PHOSPHORUS FREE GELLING AGENTS GASFRAC ENERGY SERVICES INC. (CA) 2011-06-16 US disclosed
US-20110143971-A1 VOLATILE-PHOSPHORUS FREE GELLING AGENTS GASFRAC ENERGY SERVICES INC. (CA) 2011-06-16 US disclosed
EP-0666840-A1 BENZYLAMINE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-08-16 EP disclosed
WO-1995006630-A1 BENZYLAMINE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110143971-A1 VOLATILE-PHOSPHORUS FREE GELLING AGENTS OXSR1, NR1H3, NR1H2 KDM4E 4369/4885SRC 3603/4885LMNA 4441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.